comparemela.com

Latest Breaking News On - Covid 19 drug development - Page 1 : comparemela.com

Why COVID patients who could most benefit from Paxlovid still aren t getting it | Lifestyle

FDA Revises EUA for Paxlovid; Allows State-Licensed Pharmacists to Prescribe

Today, the U.S. Food and Drug Administration (FDA) revised the  Emergency Use Authorization (EUA) for Paxlovid (nirmatrelvir and ritonavir), to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate patient assessment and prescribing of Paxlovid.

Huateng Pharma Supplies Ensitrelvir Intermeidates Against COVID-19

Ensitrelvir (code name S-217622, brand name Xocova), is a new inhibitor of the SARS-CoV-2 major protease (Mpro), also known as 3C-like protease, has been shown to reduce the viral load and help alleviate the severity of SARS-CoV-2 in infected hamsters. In cells, low nanomolar to sub-micromolar doses of Ensitrelvir suppress viral growth.

Pfizer to supply UNICEF with nearly 4 million rounds of oral COVID treatment

Pfizer has agreed to provide nearly 4 millions courses of its oral COVID-19 treatment to UNICEF to be used in 95 low- and middle-income countries.

35 global companies to start making Pfizer s antiviral pill

A United Nations -backed agency announced Thursday that 35 manufacturers had agreed to produce generic forms of Pfizer's oral antiviral treatment for COVID-19.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.